Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

NCT00633659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Vascular Disease
Critical Lower Limb Ischemia

Interventions

DRUG: Hemospan (MP4OX)
DRUG: Voluven (HES 130/0.4)

Sponsor

Sangart